KNIGHT THERAPEUTICS INC (GUD.CA) Stock Analyst Ratings
TSX:GUD - CA4990531069 - Common Stock
6.5 CAD
+0.1 (+1.56%)
ChartMill assigns a Buy % Consensus number of 78% to GUD.CA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.96. This target is 22.4% above the current price.
GUD.CA was analyzed by 10 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about GUD.CA.
In the previous month the buy percentage consensus was at a similar level.
GUD.CA was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-08-12 | Stifel Nicolaus Research | Upgrade | |
| 2022-08-12 | National Bank of Canada Financial | Upgrade | Outperform |
| 2022-03-28 | Bloom Burton | Initiate | Buy |
| 2022-03-26 | Bloom Burton | Downgrade | Buy -> Accumulate |
| 2022-03-25 | Raymond James Capital | Downgrade | Outperform |
| 2022-03-25 | National Bank of Canada Financial | Downgrade | Outperform |
| 2022-03-25 | Canaccord Capital | Upgrade | Buy |
| 2022-03-25 | National Bank Financial | Downgrade | Outperform |
| 2021-11-12 | RaymondJamesFinancial | Initiate | Outperform |
| 2021-11-12 | NationalBankFinancial | Upgrade | Outperform |
| 2021-09-24 | Raymond James Financial | Initiate | Outperform |
| 2021-08-17 | Raymond James Financial | Initiate | Outperform |
| 2021-07-13 | RBC Capital | Initiate | Outperform |
| 2021-05-17 | Raymond James Financial | Initiate | Outperform |
| 2021-04-26 | National Bank Financial | Upgrade | Outperform |
| 2021-04-26 | Raymond James Financial | Upgrade | Outperform |
| 2021-03-27 | Bloom Burton | Upgrade | Accumulate -> Buy |
| 2021-03-26 | Raymond James Financial | Initiate | Outperform |